Panel Luncheon Seminars

Hilton Americas Houston

November 2-6, 2007

Houston, Texas


Panel Luncheon Seminars

1.75 CME Credits per Seminar
($90.00 for members per Seminar,
$180.00 for non-members per Seminar)


 The Panel Luncheon Seminars are interactive lectures formatted around a single topic and presented by a nationally known expert(s). The seminars commence with  lunch and the lecture follows.  An opportunity for questions and answers is offered at the end of the seminar.


Dietary Restrictions

With advance notice, the ASC will forward our Meeting attendees’ dietary/allergy restrictions to the Hilton Americas Houston Hotel.

Dietary restrictions must be forwarded to the ASC National Office by October 1st in order to be included in the menu planning.  Those requests received after October 1st, including on-site, cannot be guaranteed.

APPROVED RESTRICTIONS: Allergies, Vegetarians, Vegans, Religious or Cultural Restrictions.

Those attendees, who have notified the ASC regarding their dietary restrictions, will receive a Dietary Restriction Card.  This card must be presented to Banquet Servers during the Annual Scientific Meeting.


Saturday, November 3, 2007
12:00 pm to 1:45 pm


Panel Luncheon #1 - Indifference and Greed:  Pity the Patient Mired in the Medicolegal Morass
     Carol Ann Armenti, M.A., J.D.

Educational Objectives:

  1. Meeting mitigation requirements of CLIA violation, while serving patient needs and avoiding economic damages
  2. Managing pathology/referring physician HIPAA, including protecting patient and avoiding violation
  3. Learning ethical legal patient contact, including gaining the support of the patient as a strategy to avoid litigation
  4. Assisting counsel during litigation, including informing the court of patient concerns

The legal requirements surrounding Pap tests are so cumbersome and time consuming, it is sometimes difficult to remember that the original purpose of the turgid system was to serve patients.  This panel uses as its framework a highly controversial, recent lawsuit which began as some missed slides, which were discovered and outsourced for third party review, and ended with the unlikely result of the patients, whose HIPAA rights were violated as part of notification of the misread slides, prosecuting a law firm, which represented a patient whose undiagnosed disease progressed to cervical cancer, together with the hospital, which originally failed to screen their Pap tests.

This panel is expected to be highly interactive with discussion of each decision point – medical, legal, judicial – examining what should have happened, what did happen, and how alternative actions could have achieved the initial purpose of protecting the patient, while permitting the healthcare facility to preserve patient trust, referring physician relations and corporate assets.


Panel Luncheon #2 - Error Management in the Cytopathology Laboratory:  Learning From Our Mistakes
     Claire W. Michael, M.D.
     Kalyani Naik, M.S., SCT(ASCP)

Educational Objectives:

  1. Explain the concept of error management and the role it plays in the overall quality management system
  2. Explore Process Improvement (PI) tools that can be used to identify and analyze root cause
  3. Apply PI tools to create interventions

The topic of error reduction and patient safety in healthcare has recently come to the forefront of medical practice, particularly since the publication of the Institute of Medicine’s reports on medical error (1999) and the general quality of healthcare (2001).  Though it is relatively new to the cytopathology laboratory, many areas of medicine are applying process improvement tools and methods that have been successfully employed in manufacturing for years to reduce error, improve processes and reduce waste.  This panel luncheon will introduce the concept of error management as a component of a quality management system with emphasis on practical process improvement tools that can be used to identify and analyze root cause of laboratory errors,  Interactive case studies of errors that occur in the cytopathology laboratory will be utilized to give participants the opportunity to apply process improvement tools.


Panel Luncheon #3 - The Billing & Coding Alphabet:  From Admission to Zero Balance and All the Acronyms in Between
     Michele Smith, SCT(ASCP), CMC
     John Shalkham, M.A., SCT(ASCP)

Educational Objectives:

  1. Describe the value of accurate billing
  2. Explain the financial and legal costs of inaccurate billing
  3. Explain Government billing rules
  4. Explain Non-Government billing rules

What laboratory would be in business if their diagnostic results were correct only 50% of the time?  This is what happens to many laboratory billing claims around the country.  As health dollars expand and shrink, laboratory professionals play an ever more important role in maintaining the revenue cycle.  This panel will review how daily laboratory routine follows the revenue cycle; describe the laboratory’s role in maintaining medical necessity for appropriate and complete coding in order to produce a clean claim the first time around; and provide practical examples of how to use ICD-9, CPT and HCPCS codes.


Sunday, November 4, 2007
12:00 pm to 1:45 pm


Panel Luncheon #4 – Teaching Cytotechnologists to FISH:  Integrating Fluorescence in situ Hybridization into Our Cytopathology Laboratories
     Kevin Halling, M.D., Ph.D.
     Amy Wendel, SCT, MP(ASCP)
     Benjamin Kipp, M.S., CT, MP(ASCP)  

Educational Objectives:

  1. Familiarize participants with terminology, theories and principles of FISH technology
  2. Outline the process for establishing a training program within the cytology lab, based on current practice techniques
  3. Identify training initiatives, objectives and training resources

Fluorescence in situ hybridization (FISH) is a molecular diagnostic tool that is becoming more commonplace in our cytology laboratory settings.  Further, as part of the repertoire of ancillary techniques that are utilized in diagnoses, cytotechnologists will need to be well-versed in this mode of analysis.  Currently however, there is no formal training for cytotechnologists who work with this unique process.  Our presentation will provide participants with a framework of training techniques for cytotechnologists through outcomes-based objectives and modules.  Further, we will address the specific FISH testing modalities our laboratory utilizes, highlighting their clinical implications.  Likewise, we will familiarize participants as to the role of research and development in the FISH laboratory.


Panel Luncheon #5 – Immunocytochemistry in Diagnostic Cytology: Values and Limitations
     Parvin Ganjei-Azar, M.D.
     Merce Jorda, M.D., Ph.D.

Educational Objectives:

  1. Discuss the practical applications of ICC in resolution of common diagnostic problems
  2. Understand potential pitfalls of the technique and interpretation when cytologic material is used
  3. Be able to select a limited antibody panel based on clinical information and cytomorphology

This course is intended to familiarize the cytopathologists, surgical pathologists, and pathology residents and fellows with the value and limitations of ICC indiagnostic cytology.  We will particularly stress the application of the technique directly to cytologic smears from a variety of sources including fine needle aspirations, body cavity fluids, and brush and wash specimens when cell-blocks are not available. First, the technical aspects of ICC will be presented including the potential technical and analytical pitfalls and means to avoid them.  This will be followed by the practical application of ICC in resolution of common differential diagnostic problems of primary and metastatic malignancies.  The use of limited antibody panels based on clinical information, and cytomorphology will be discussed in detail.  A short quiz will be presented at the completion to emphasize the practical points discussed during the program.


Panel Luncheon #6 – Cyto-Colposcopic Discrepancies: What Should You and the Clinician Do Next?
     Mujtaba Husain, M.D., FIAC
     Carl W. Christensen, M.D., Ph.D.

Educational Objectives:

  1. Becoming familiar with morphologic presentation of CIN/SIL in cytology, biopsy and LEEP media
  2. Correlations of index cytology with Colposcopy and biopsy findings
  3. Becoming familiar with ASCCP clinical guidelines for management of abnormal cytology and biopsy
  4. To become proficient in triaging non-correlating colposcopy of cytology and becoming familiar with the role of HPV testing for various cytologic abnormalities

Cytopathologist and colposcopist with extensive experience in cyto-histologic-colposcopic correlation will utilize case presentations highlighting the frequency and kind of discrepancies for various cytological categories including ASC-US, ASC-H, HSIL, AGC, inadequate specimens, and malignancies.  The format of presentation will include review of index Pap, colposcopic data or images, biopsy and LEEP specimens, and pertinent HPV data.  The purpose of this presentation is to highlight the teamwork involved between the cytologist, surgical pathologist and colposcopist to bring about closure for woman and clinician for borderline abnormalities and to pursue significant discrepancies as outlined in the revised ASCCP Clinical Management Guidelines.


Monday, November 5, 2007
12:00 pm to 1:45 pm


Panel Luncheon #7 – The International Academy of Cytology Seminar: Cervical Cancer Screening in Africa and Latin America
     Hormoz Ehya, M.D.
     Bryan Knight, MB, ChB; M Med Path (Anat); FIAC
     Patricia Alonso de Ruiz, M.D., FIAC

Educational Objectives:

  1. To become familiar with opportunities and problems of cervical  cancer screening in the   developing world
  2. To learn about specific problems in South Africa and Mexico as well as neighboring countries
  3. To understand the current global policy debate on which technology best serves the developing world as discussed by faculty thoroughly familiar with these issues in their native countries

This is the second of a series of seminars sponsored by the International Academy of Cytology aimed to increase the awareness of American professionals about the status of cytopathology in other countries. This time, the seminar is devoted to cervical cancer screening in Africa and Latin America.  In a way, these two continents represent the entire spectrum of possible applications of cervical cancer screening. Whereas the African continent is ravaged by AIDS and other infectious diseases making cervical cancer screening a questionable exercise in view of limited funds and infrastructure, the situation in Latin America is very complex with several successful regional screening programs. The controversies and opportunities of cervical cancer prevention in the developing world will be discussed.


Panel Luncheon #8 – Validation in the Cytology Laboratory
     Lori A. Haack, B.S., SCT(ASCP)
     John E. Shalkham, M.A., SCT(ASCP)

Educational Objectives:

  1. Define validation
  2. Explain the role of validation in the cytology laboratory
  3. Review the regulatory requirements for validation
  4. Outline the validation process
  5. Review examples of validation

The cytology laboratory has traditionally performed a small variety of tests employing manual processes.  Recent changes in technology have led to the increased use of instrumentation and complex test methods in cytopathology.  This panel luncheon will discuss the application of validation process in the cytopathology laboratory and will provide a detailed outline of how the validation process is used.  Examples of validation studies will be provided to demonstrate practical application of the process.


Panel Luncheon #9 – ImmunoCytTM, UroVysionTM, and Other Immunocytochemical Markers – How Can We Use Them in Daily Practice of Urine Cytology?

     Jianyu Rao, M.D.
     Oscar Lin, M.D.
     Mary Levin, SCT(ASCP)

Educational Objectives:

  1. To learn the basics of urine cytology and understand the limitations of cytomorphology
  2. To compare the test characteristics (sensitivity, specificity, PPV and NPV) of two commercially available fluorescence-based cellular tests,  UroVysionTM and ImmunoCytTM, for the detection of urothelial carcinoma
  3. To learn some of the potential simple immunocytochemical tests including PSCA (Prostate Stem Cell Antigen) and CK20, for the detection of urothelial carcinoma
  4. To learn how to use these cellular in helping the diagnosis, especially atypical cases on a daily basis

Urine cytology and cystoscopy are two complement tests for urothelial cancer.  However, cystoscopy is invasive, and urine cytology has low sensitivity for low grade tumors.  Efforts have been devoted to develop urine biomarkers.  Recently two fluorescence-based commercial tests (ImmunoCytTM and UroVysionTM) have been developed.  The ImmunoCytTM test is an antibody-based test whereas UroVysionTM is a DNA-based fluorescence in situ hybridization.  The symposium will discuss the performance characteristics of these two tests, and two immuncytochemical markers PSCA and CK20.   The algorithms of how to use these tests in daily sign out of urine cytology will also be discussed.